Lonza Group Teva Pharmaceutical Industries Discontinue Their Joint Venture For Biosimilars

Lonza, Teva to terminate biosimilars JV

6:25 AM, 26th July 2013
Lonza Group Business news

JERUSALEM, ISRAEL/BASEL, SWITZERLAND: Global leader in pharmaceutical ingredients, Lonza Group and Teva Pharmaceutical Industries have decided to discontinue their collaboration (Teva – Lonza joint venture) for the development, manufacturing and marketing of biosimilars. The joint venture was established in 2009. The discontinuation will enable both companies to better advance their own strategies and efforts in serving those healthcare communities. Both companies will continue to explore opportunities to maximize the value of the investments and progress for affordable, efficacious and safe biosimilar treatments.

“With the discontinuation of the joint venture we will cease investing in areas that are not strategic to Lonza such as clinical developments and end product commercialization. In our assessment those investments in biosimilar will require more capital than initially planned and will also take more time until they reach the market. This is why we intend in the future to limit our role by focusing on our core expertise in the areas of contract manufacturing and cell line development,” said Dr Stephan Kutzer, COO, Pharma & Biotech Market Segment, Lonza.


© Worldofchemicals News 



Your Comments (Up to 2000 characters)
Please respect our community and the integrity of its participants. WOC reserves the right to moderate and approve your comment.

Related News

Nitric acid leakage occurs at Orica’s manufacturing facility

VICTORIA, AUSTRALIA: A nitric acid leakage occurred at Orica’s Kooragang Island manufacturing facility near Newcastle, Australia. The leak was f ...

Read more
Ashland plans to sell water technologies unit, elastomers unit

WILMINGTON, US: Ashland Inc plans to sell an elastomers unit and will consider the divestment of a water-treatment business. These transactions could ...

Read more
Charge mobile phones using urine

BRISTOL, UK: Scientists have developed a novel way of charging mobile phones using urine as the power source to generate electricity. Dr Ioannis Ierop ...

Read more
Synthesis Energy expands methanol JV in China

HOUSTON, US: Synthesis Energy Systems Inc, the US based energy and gasification technology company, has entered into a definitive agreement with Xuech ...

Read more
FMC acquires Omega-3 manufacturers in Norway, UK

PHILADELPHIA, US: FMC Corporation has acquired all of the shares of Epax Nutra Holding III AS, Norway and Epax UK Holding III AS, UK, manufacturers of ...

Read more
Sasol, Ineos to manufacture high density polyethylene

HOUSTON, US: Sasol, South African-based energy and chemical company, and Ineos Olefins & Polymers have signed of a memorandum of understanding (MO ...

Read more
www.worldofchemicals.com uses cookies to ensure that we give you the best experience on our website. By using this site, you agree to our Privacy Policy and our Terms of Use. X